PHA-848125 (Milciclib)
目录号: A11047
CDK 抑制剂
PHA-848125(Milciclib)是一种口服生物可用的CDKs和TRKA抑制剂,具有潜在的抗肿瘤活性。
Discription | PHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A11047 |
---|---|
分子式 | C25H32N8O |
分子量 | 460.6 |
CAS号 | 802539-81-7 |
SMILES | CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C |
其他名称 | Milciclib, PHA848125 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 91 mg/mL (197.58 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.71 mL | 108.55 mL | 217.11 mL |
0.5 mM | 4.34 mL | 21.71 mL | 43.42 mL |
1 mM | 2.17 mL | 10.86 mL | 21.71 mL |
5 mM | 0.43 mL | 2.17 mL | 4.34 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2